Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Study Identifier
192371-011-01
CT.gov Identifier
NCT00025818
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
  • Immune & Inflammatory - Other
  • Lupus (Systemic Lupus Erythematosus (SLE))
  • Rheumatoid Arthritis
    • Study Drug
  • Ophthalmic Emulsion
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Eighteen years or older * Diagnosis of moderate to severe dry eyes for at least 6 months and meet one or all of the following criteria: * Diagnosis of autoimmune disorder * Female 65 years of age or older

    Protocol Summary

    A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.

    Study Locations

    Location
    Status
    Location
    Eyecare of La Jolla
    La Jolla, California, United States, 92037
    Status
    Not applicable
    Location
    UCLA
    Los Angeles, California, United States, 90095
    Status
    Not applicable
    Location
    Opticare
    Waterbury, Connecticut, United States, 06708
    Status
    Not applicable
    Location
    Brandon Eye Clinic
    Tampa, Florida, United States, 33629
    Status
    Not applicable
    Location
    Emory University
    Atlanta, Georgia, United States, 30322
    Status
    Not applicable
    Location
    UIC Eye Center
    Chicago, Illinois, United States, 60612
    Status
    Not applicable
    Showing {first} - {last} of {total} Results